Doctor profile · Federal record
Dr. Atam Singh, M.D.
Endocrinology, Diabetes & Metabolism Physician (CMS: Internal Medicine) · Riverside, CA
- NPI 1548271166
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 52 yrs in practice
- Male
- Solo practice
- No sanctions
Practice & contact
- Primary practice
-
5256 Mission Blvd
Riverside, CA 925094624
(951) 955-5380
fax (951) 955-5388
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- October 2, 2012
- Year of graduation
- 1974 — 52 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- California #A66788
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1548271166. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
3,015
Distinct HCPCS
5
Medicare allowed
$381,477
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,733 | 780 | $130 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 479 | 197 | $175 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 388 | 135 | $35 | |
99443 |
Telephone medical discussion with physician, 21-30 minutes | 295 | 158 | $131 | |
99204 |
New patient office or other outpatient visit, 45-59 minutes | 120 | 120 | $169 |
In context: peer comparison
Among 3 peers in Riverside Endocrinology, Diabetes & Metabolism Physician, average services per provider: 305. This provider delivers 9.9× the peer median.Open Payments
Industry payments received
All-time total
$1,107
Transactions
49
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Novo Nordisk INC | 16 | $310.89 | |
| Ascensia Diabetes Care US INC. | 6 | $118.78 | |
| Lilly USA, LLC | 5 | $97.67 | |
| Amgen INC. | 4 | $81.65 | |
| Abbvie INC. | 3 | $81.57 | |
| Ultragenyx Pharmaceutical INC. | 3 | $74.46 | |
| Medtronic, INC. | 2 | $66.42 | |
| Mannkind Corporation | 3 | $57.86 | |
| CeQur Corporation | 1 | $27.59 | |
| Ascendis Pharma INC | 1 | $24.42 | |
| Averitas Pharma INC. | 1 | $23.55 | |
| Abbott Laboratories | 1 | $22.59 | |
| AstraZeneca Pharmaceuticals Lp | 1 | $21.22 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | 1 | $21.11 | |
| Antares Pharma, INC. | 1 | $20.90 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
3,673
Patients
977
Total drug cost
$1,901,619
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Levothyroxine Sodium | Generic | 641 | 149 | $12,041 |
| Trulicity (Dulaglutide) | Brand | 463 | 94 | $619,875 |
| Ozempic (Semaglutide) | Brand | 412 | 89 | $453,766 |
| Metformin Hcl | Generic | 398 | 119 | $3,622 |
| Novolog Flexpen (Insulin Aspart) | Brand | 245 | 75 | $215,329 |
| Lantus Solostar (Insulin Glargine,Hum.Rec.Anlog) | Brand | 241 | 69 | $136,034 |
| Glipizide | Generic | 237 | 64 | $3,109 |
| Jardiance (Empagliflozin) | Brand | 215 | 59 | $232,116 |
| Nano 2Nd Gen Pen Needle (Pen Needle, Diabetic) | Brand | 180 | 71 | $20,347 |
| Basaglar Kwikpen U-100 (Insulin Glargine,Hum.Rec.Anlog) | Brand | 163 | 45 | $70,492 |
Hospital affiliations
Frequently asked questions
What is Dr. Atam Singh's medical specialty?
Dr. Atam Singh practices Endocrinology, Diabetes & Metabolism Physician in Riverside, CA.
Where does Dr. Atam Singh practice?
Dr. Atam Singh practices at 5256 Mission Blvd, Riverside, CA 925094624. Office phone: 9519555380.
What is Dr. Atam Singh's NPI?
Dr. Atam Singh's National Provider Identifier (NPI) is 1548271166, issued by NPPES.
Does Dr. Atam Singh accept Medicare assignment?
Yes. Dr. Atam Singh accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Atam Singh commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Established patient office or other outpatient visit (HCPCS 99215); Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report (HCPCS 95251). Source: CMS Medicare Physician & Other Practitioners file.